These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 8622106

  • 1. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G, Giamarellou H, Tsagaraki C, Pefanis A.
    J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
    [Abstract] [Full Text] [Related]

  • 2. An overview of the safety of isepamicin in adults.
    Blum D.
    J Chemother; 1995 Jun; 7 Suppl 2():87-93. PubMed ID: 8622116
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E, Esparza-Ahumada S, Morfin-Otero R.
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [Abstract] [Full Text] [Related]

  • 4. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Carbon C.
    J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F.
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M, Velluti G.
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [Abstract] [Full Text] [Related]

  • 7. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS, Liu YC, Wann SR, Lin WR, Tsai TH, Lin HH, Chen YS, Yen MY.
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [Abstract] [Full Text] [Related]

  • 8. Isepamicin versus amikacin in the treatment of urinary tract infection.
    Sturm W.
    J Chemother; 1995 Jun; 7 Suppl 2():149-54. PubMed ID: 8622104
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections.
    Leal del Rosal P.
    J Chemother; 1995 Jun; 7 Suppl 2():143-8. PubMed ID: 8622103
    [Abstract] [Full Text] [Related]

  • 10. A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
    Viganò A, Principi N.
    J Chemother; 1995 Jun; 7 Suppl 2():95-101. PubMed ID: 8622117
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Beaucaire G.
    J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C, Li J, Hou J, Guo M, Zhang Y, Chen Y.
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [Abstract] [Full Text] [Related]

  • 13. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R, Blaise D, Espinouse D, Leblond V, Sadoun A, Sauvage C, Cordonnier C, Minozzi C.
    J Chemother; 1995 Jun; 7 Suppl 2():103-10. PubMed ID: 8622099
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [Abstract] [Full Text] [Related]

  • 15. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
    Kreter B.
    Clin Ther; 1992 May; 14(1):110-21. PubMed ID: 1576620
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections.
    Stotka JL, Senetar JE, Therasse DG, Dere WH.
    Postgrad Med J; 1992 May; 68 Suppl 3():S73-7; discussion S78-80. PubMed ID: 1287622
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with moxifloxacin in patients with respiratory tract infections.
    Faich GA, Morganroth J, Whitehouse AB, Brar JS, Arcuri P, Kowalsky SF, Haverstock DC, Celesk RA, Church DA.
    Ann Pharmacother; 2004 May; 38(5):749-54. PubMed ID: 15026565
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL, Smith BR, Chandrasekar P, Rolston KV, Molavi A, Kannangara W.
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [Abstract] [Full Text] [Related]

  • 19. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G.
    Clin Ther; 1983 Feb; 5(4):342-7. PubMed ID: 6347380
    [Abstract] [Full Text] [Related]

  • 20. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG, Woods GL, Jiang Q, Gesser RM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.